Black Rock Inc. Regenxbio Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Regenxbio Inc. stock. As of the latest transaction made, Black Rock Inc. holds 7,599,242 shares of RGNX stock, worth $81.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,599,242

Previous 8,207,548 7.41%

Holding current value

$81.7 Million

Previous $147 Million 8.68%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$12.17 - $24.61 $7.4 Million - $15 Million	-608,306 Reduced 7.41%	7,599,242 $160 Million
Q4 2023 Feb 13, 2024	BUY	$12.89 - $20.82 $2.33 Million - $3.77 Million	181,058 Added 2.26%	8,207,548 $147 Million
Q3 2023 Nov 13, 2023	SELL	$16.46 - $19.99 $3.99 Million - $4.85 Million	-242,482 Reduced 2.93%	8,026,490 $132 Million
Q2 2023 Aug 11, 2023	BUY	$17.23 - $21.71 $3.93 Million - $4.95 Million	228,182 Added 2.84%	8,268,972 $165 Million
Q1 2023 May 12, 2023	BUY	$18.08 - $24.55 $24.5 Million - $33.3 Million	1,354,440 Added 20.26%	8,040,790 $152 Million

Q4 2022 Feb 13, 2023	BUY	$20.4 - $24.73 $2.76 Million - $3.34 Million	135,074 Added 2.06%	6,686,350 $152 Million
Q3 2022 Nov 14, 2022	SELL	$22.29 - $35.04 $1.71 Million - $2.69 Million	-76,847 Reduced 1.16%	6,551,276 $173 Million
Q2 2022 Aug 12, 2022	BUY	$19.35 - $35.04 $760,609 - $1.38 Million	39,308 Added 0.6%	6,628,123 $164 Million
Q1 2022 May 12, 2022	BUY	$24.62 - $34.31 $427,821 - $596,204	17,377 Added 0.26%	6,588,815 $219 Million
Q4 2021 Feb 10, 2022	BUY	$30.19 - $40.28 $6.33 Million - $8.44 Million	209,635 Added 3.3%	6,571,438 $215 Million
Q3 2021 Nov 09, 2021	BUY	$29.09 - $45.68 $4.67 Million - $7.34 Million	160,702 Added 2.59%	6,361,803 $267 Million
Q2 2021 Aug 11, 2021	BUY	$32.46 - $40.48 $201 Million - $251 Million	6,201,101 New	6,201,101 $241 Million

Others Institutions Holding RGNX

# of Institutions

192

Shares Held

42.1M

Call Options Held

80.6K

Put Options Held

55.2K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $465M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account